Isomorphic lands deals with Lilly, Novartis worth nearly $3B

Just more than two years after launching within Alphabet, Isomorphic has inked two large pharma deals with Eli Lilly and Novartis with nearly $3 billion in combined deal value.  | Just more than two years after launching within Alphabet, Isomorphic has inked two large pharma deals with Eli Lilly and Novartis with nearly $3 billion in combined deal value. 

MedTech News - Medical Innovation Exchange

Max Bayer Fierce Biotech

Michael Jackson on LinkedIn: #technology #tech #innovation #science #deeptech #ai…

BioWorld: The Daily Biopharmaceutical News Source

Shiv Chiruvolu on LinkedIn: Texas engineers land semiconductor grants through CHIPS Act-backed NSF…

Max Bayer Fierce Pharma

Michael Jackson on LinkedIn: #vc #venturecapital #startups #entrepreneurs #entrepreneurship #tech…

BioWorld: The Daily Biopharmaceutical News Source

Steve Harvey on LinkedIn: Zoom interview tips

William Stone B.Sc on LinkedIn: This is nothing short but spectacular! Such an inspiration! Massive…

Max Bayer Fierce JPM Week

Max Bayer Fierce Biotech

AI and Machine Learning

Chris McKay - Maginative